225 results on '"Yun, Kyuson"'
Search Results
2. DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
3. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
4. TMIC-60. CROSS-SPECIES ANALYSIS OF HUMAN AND NEW MOUSE MODELS OF GBM SUBTYPES IDENTIFIES VISTA AS A PROMISING IMMUNOTHERAPY TARGET
5. TMIC-45. SEX DIFFERENCES IN YAP1-CD276 EXPRESSION AND FUNCTION IN MEDULLOBLASTOMA IMMUNE EVASION
6. A prognostic matrix code defines functional glioblastoma phenotypes and niches
7. Author Correction: Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
8. A prognostic matrix code defines functional glioblastoma phenotypes and niches
9. Supplementary Table 5 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
10. Supplementary Table 7 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
11. Abstract 5871: Pan-cancer myeloid cell analysis at the single cell level reveals the influence of distinct organ sites in myeloid cell phenotypes and support targeting S100A4 to reverse immune suppression
12. Abstract 2948: A humanized therapeutic antibody against S100A4 as a novel immune modulator and an inhibitor of cancer metastasis
13. Supplementary Table 8 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
14. Supplementary Table 9 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
15. Supplementary Figures and Tables 1-2 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
16. Abstract 4563: Measuring immunotherapy responses ex vivo using novel 3D culture platform: E-slice
17. Supplementary Table 4 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
18. Supplementary Table 6 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
19. Supplementary Table 3 from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
20. Data from Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors
21. 370 Single-Cell Analysis of Human Glioma and Immune Cells Identifies S100A4 as an Immunotherapy Target
22. Data from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
23. Table S4 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
24. Supplementary Methods and figure legends from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
25. Supplementary Figures from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
26. Supplementary Table 1 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
27. Supplementary Methods from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
28. Data from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
29. Supplementary Figure Legends from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
30. Supplementary Figure 5 from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
31. Supplementary Figure Legend from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
32. Supplementary Figure 6 from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
33. Supplementary Figure 2 from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
34. Supplementary Figure 3 from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
35. Supplementary Figure 4 from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
36. Supplementary Figure 4 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
37. Supplementary Figure 6 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
38. Supplementary Figure 1 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
39. Supplementary Methods from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
40. Supplementary Figure 3 from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
41. Supplementary Tables 1-5 from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
42. Supplementary Figure 3 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
43. Data from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
44. Supplementary Figure 1 from Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
45. Supplementary Figure 2 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
46. Data from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
47. Supplementary Figure 2 from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
48. Supplementary Figure 1 from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
49. Supplementary Figure 5 from Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
50. Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.